Drawing for XIL

USPTO serial 98668931

XIL

Reviewed by CopyMark Law Group

Reg. 7761981Status 700Registered
Filing date
Status date
Registration date
Apr 15, 2025
Examiner
SAUNDERS, ANDREA DAWN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with XIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis JM Donahue III

Dennis JM Donahue III Carmody MacDonald P.C.120 S. Central Ave., Suite 1800TM Matter - Refer Notice to D. DonahueSt. Louis, MO 63105

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the field of medical costs and pharmacy benefit management for retail pharmacies, pharmacy benefit managers, drug wholesalers, generic drug manufacturers, brand drug manufacturers, and medical device manufacturers and wholesalers; Business management and consultation in the field of medical costs and pharmacy benefit management; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciencesACTIVEJan 26, 2019
042Cloud computing featuring software for use in management and analysis of healthcare costs; Providing on-line non-downloadable software for management and analysis of data in the field of drug costs, pharmacy benefit management, and retail pharmacy services; Software as a service (SAAS) services featuring software for management and analysis of data in the field of drug costs, pharmacy benefit management, and retail pharmacy servicesACTIVENov 15, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2025DOCKASSIGNED TO EXAMINER—
Jan 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 8, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance